Table 1.
Clinic characteristics of the patients included
| PCa group (n=94) | NEM group (n=113) | P-value | |
|---|---|---|---|
| Age (years) | 63 (54-77) | 65 (49-78) | 0.395 |
| History of chronic prostatitis | 14 (14.89%) | 12 (10.62%) | 0.248 |
| Family history of cancer | 4 (4.26%) | 3 (2.65%) | 0.526 |
| t-PSA (ng/mL) | 12.6 (6.4-42.5) | 7.6 (5.60-35.5) | 0.009* |
| % fPSA | 16.4 (3.3-29.7) | 17.7 (6.3-37.9) | 0.068 |
| PHI value | 57.8 (22.8-256) | 33.8 (17.6-124) | 0.018* |
| Prostate volume (cm3) | 47.2 (19.1-118.2) | 56.4 (20.4-122.1) | 0.023* |
| DRE, n (%) | |||
| Positive | 30 (31.91%) | 23 (20.35%) | |
| Negative | 64 (68.09%) | 90 (79.65%) | 0.258 |
| PCA3 score | 35.6 (14.2-212) | 19.4 (6.5-145) | 0.014* |
PCa, prostate cancer; NEM, no evidence of malignancy; t-PSA, total prostate-specific antigen; fPSA, free prostate-specific antigen; PHI, prostate health index; DRE, digital-rectal examination; PCA3, prostate cancer associated 3.
*
P<0.05 by Mann-Whitney U-test or Fisher exact test.